On New Year’s day GoLocalProv announced that it had selected Stephen Salloway, M.D. as its Man of the Year for 2019. Dr. Salloway, a world leader in Alzheimer’s research, is director of Neurology and the Memory and Aging Program at Butler Hospital and Martin M. Zucker professor of psychiatry and human behavior, professor of neurology at Alpert Medical School of Brown University. The honor comes after Dr. Salloway was also inducted into the Rhode Island Heritage Hall of Fame in May, 2019.
Dr. Salloway’s professional accomplishments and contributions to the field of Alzheimer’s research are staggering and continue to grow. As the founding director of the Memory and Aging Program at Butler Hospital, for the last 22 years he has, from his offices on the Butler Hospital campus right here in Rhode Island, played a major role in advancing the study and treatment of Alzheimer’s disease and dementia for the entire world.
Under his direction the program has conducted over 100 clinical trials and research studies. Each of them has provided another small step forward in the fight against Alzheimer’s through deeper insights and understanding into how the disease develops, how it can be diagnosed earlier and more accurately, and how it might then be treated more effectively or even prevented altogether. Today, those many small steps are building to what Dr. Salloway and his team hope will be a giant leap in Alzheimer’s treatment in the next several years.
Major Alzheimer’s Association grant to enable researchers to test a drug that could slow the progression of Alzheimer’s disease.
With a special combination of compassionate care and scientific inquiry, she’s part of the front-line fight to end Alzheimer’s.
Ray and Elaine Theriault have embarked on many journeys in their 50+ years together. Now they’re on a new quest: to help end Alzheimer’s.
Drug Studied at Butler Hospital’s Memory and Aging Program May Become First New Treatment for Alzheimer’s in 16 Years
Aducanumab maker Biogen seeking FDA review in early 2020; if approved, it will become the first drug to remove amyloid protein from the brain and slow the progression of Alzheimer’s disease (AD).
Dr. Hwamee Oh Named Director of Imaging Research for The Memory and Aging Program at Butler Hospital
Dr. Oh will research the use of imaging to detect Alzheimer’s before symptoms appear, offering patients a chance at early intervention.
Marc Archambault has early-onset Alzheimer’s disease, but that’s not stopping him from living his best life – or inspiring others to do the same.
With a powerful range of skills and an inspiring amount of passion, these women are engaging others in the fight against Alzheimer’s.
Susan Saccoccia-Olson knows a lot about Alzheimer’s; she’s lost both of her parents to the
devastating disease. Now, she’s fighting back.
Brown University student Jackie Ho lost her grandmother to Alzheimer’s. Now she’s trying to change the future of the disease for others.